205 related articles for article (PubMed ID: 35661128)
1. External Concurrent Occipital and Trigeminal Neurostimulation Relieves Migraine Headache: A Prospective, Randomized, Double-Blind, Sham-Controlled Trial.
Daniel O; Tepper SJ; Deutsch L; Sharon R
Pain Ther; 2022 Sep; 11(3):907-922. PubMed ID: 35661128
[TBL] [Abstract][Full Text] [Related]
2. Migraine treatment with external concurrent occipital and trigeminal neurostimulation-A randomized controlled trial.
Tepper SJ; Grosberg B; Daniel O; Kuruvilla DE; Vainstein G; Deutsch L; Sharon R
Headache; 2022 Sep; 62(8):989-1001. PubMed ID: 35748757
[TBL] [Abstract][Full Text] [Related]
3. Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
Yarnitsky D; Dodick DW; Grosberg BM; Burstein R; Ironi A; Harris D; Lin T; Silberstein SD
Headache; 2019 Sep; 59(8):1240-1252. PubMed ID: 31074005
[TBL] [Abstract][Full Text] [Related]
4. Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial.
Chou DE; Shnayderman Yugrakh M; Winegarner D; Rowe V; Kuruvilla D; Schoenen J
Cephalalgia; 2019 Jan; 39(1):3-14. PubMed ID: 30449151
[TBL] [Abstract][Full Text] [Related]
5. A device review of Relivion®: an external combined occipital and trigeminal neurostimulation (eCOT-NS) system for self-administered treatment of migraine and major depressive disorder.
Daniel O; Sharon R; Tepper SJ
Expert Rev Med Devices; 2021 Apr; 18(4):333-342. PubMed ID: 33787443
[No Abstract] [Full Text] [Related]
6. Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM).
Kuruvilla DE; Mann JI; Tepper SJ; Starling AJ; Panza G; Johnson MAL
Sci Rep; 2022 Mar; 12(1):5110. PubMed ID: 35332216
[TBL] [Abstract][Full Text] [Related]
7. Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial.
Martelletti P; Barbanti P; Grazzi L; Pierangeli G; Rainero I; Geppetti P; Ambrosini A; Sarchielli P; Tassorelli C; Liebler E; de Tommaso M;
J Headache Pain; 2018 Nov; 19(1):101. PubMed ID: 30382909
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study.
Dodick DW; Silberstein SD; Reed KL; Deer TR; Slavin KV; Huh B; Sharan AD; Narouze S; Mogilner AY; Trentman TL; Ordia J; Vaisman J; Goldstein J; Mekhail N
Cephalalgia; 2015 Apr; 35(4):344-58. PubMed ID: 25078718
[TBL] [Abstract][Full Text] [Related]
9. Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial.
Grazzi L; Tassorelli C; de Tommaso M; Pierangeli G; Martelletti P; Rainero I; Geppetti P; Ambrosini A; Sarchielli P; Liebler E; Barbanti P;
J Headache Pain; 2018 Oct; 19(1):98. PubMed ID: 30340460
[TBL] [Abstract][Full Text] [Related]
10. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM
Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled study.
Silberstein SD; Dodick DW; Saper J; Huh B; Slavin KV; Sharan A; Reed K; Narouze S; Mogilner A; Goldstein J; Trentman T; Vaisman J; Ordia J; Weber P; Deer T; Levy R; Diaz RL; Washburn SN; Mekhail N
Cephalalgia; 2012 Dec; 32(16):1165-79. PubMed ID: 23034698
[TBL] [Abstract][Full Text] [Related]
12. One-Year Consistent Safety, Utilization, and Efficacy Assessment of Remote Electrical Neuromodulation (REN) for Migraine Treatment.
Synowiec A; Stark-Inbar A; Weinstein M; Ironi A; Mauskop A
Adv Ther; 2024 Jan; 41(1):170-181. PubMed ID: 37855973
[TBL] [Abstract][Full Text] [Related]
13. Occipital Nerve Stimulation for Refractory Chronic Migraine: Results of a Long-Term Prospective Study.
Rodrigo D; Acin P; Bermejo P
Pain Physician; 2017; 20(1):E151-E159. PubMed ID: 28072807
[TBL] [Abstract][Full Text] [Related]
14. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
[TBL] [Abstract][Full Text] [Related]
15. Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study.
Silberstein SD; Mechtler LL; Kudrow DB; Calhoun AH; McClure C; Saper JR; Liebler EJ; Rubenstein Engel E; Tepper SJ;
Headache; 2016 Sep; 56(8):1317-32. PubMed ID: 27593728
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study).
Cady RK; McAllister PJ; Spierings EL; Messina J; Carothers J; Djupesland PG; Mahmoud RA
Headache; 2015 Jan; 55(1):88-100. PubMed ID: 25355310
[TBL] [Abstract][Full Text] [Related]
17. Greater occipital nerve blockade for the preventive treatment of chronic migraine: A randomized double-blind placebo-controlled study.
Chowdhury D; Tomar A; Deorari V; Duggal A; Krishnan A; Koul A
Cephalalgia; 2023 Feb; 43(2):3331024221143541. PubMed ID: 36739512
[TBL] [Abstract][Full Text] [Related]
18. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J
Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
[TBL] [Abstract][Full Text] [Related]
19. Transcutaneous Supraorbital Nerve Stimulation (t-SNS) with the Cefaly
Riederer F; Penning S; Schoenen J
Pain Ther; 2015 Oct; 4(2):135-47. PubMed ID: 26467451
[TBL] [Abstract][Full Text] [Related]
20. Migraine Prevention Using Different Frequencies of Transcutaneous Occipital Nerve Stimulation: A Randomized Controlled Trial.
Liu Y; Dong Z; Wang R; Ao R; Han X; Tang W; Yu S
J Pain; 2017 Aug; 18(8):1006-1015. PubMed ID: 28428093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
